Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma

Metallothionein-3 has poorly characterized functions in neuroblastoma. Cisplatin-based chemotherapy is a major regimen to treat neuroblastoma, but its clinical efficacy is limited by chemoresistance. We investigated the impact of human metallothionein-3 (hMT3) up-regulation in neuroblastoma cells an...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigo, Miguel Angel Merlos, Michalkova, Hana, Strmiska, Vladislav, Casar, Berta, Crespo, Piero, de los Rios, Vivian, Ignacio Casal, J., Haddad, Yazan, Guran, Roman, Eckschlager, Tomas, Pokorna, Petra, Heger, Zbynek, Adam, Vojtech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943580/
https://www.ncbi.nlm.nih.gov/pubmed/33750814
http://dx.doi.org/10.1038/s41598-021-84185-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943580/
https://www.ncbi.nlm.nih.gov/pubmed/33750814
http://dx.doi.org/10.1038/s41598-021-84185-x

Ejemplares similares